Exploring Producer Cell Development for Lentiviral Vector Manufacturing
Stable producer cell lines show real promise despite continued development challenges.
Waters Launches SEC Columns for Gene Therapy Applications
Waters XBridge Premier GTx BEH size exclusion chromatography (SEC) columns are designed to improve analysis while lowering the cost of gene therapies.
Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership
Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.
AbbVie Expands Collaboration with Calibr to Advance Clinical Assets
The partnership is an extension of the collaboration from AbbVie and Scripps Research that was formed in 2019, according to the press release.
Bristol Myers Squibb and Evotec Extend Neuroscience Pact
Under a global license agreement, Bristol Myers Squibb and Evotec will advance the development of neurodegeneration pipeline assets.
Pfizer and Flagship Pioneering Enter Innovation Partnership
The partnership will see Flagship and Pfizer work to create a new pipeline of innovative medicines.
Sanofi and Scribe Therapeutics Expands Genomics Collaboration
The expanded deal, now potentially worth more than $1.2 billion, will work to develop in vivo therapies, including sickle cell disease.
Novartis Acquires DTx Pharma in Deal Worth Up to $1 Billion
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.
